These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
93 related articles for article (PubMed ID: 7699581)
21. [Effects of SIN-1, a metabolite of molsidomine, on paf-acether-blood platelets interactions]. Nunez D; Russo-Marie F; Benveniste J Pathol Biol (Paris); 1987 Feb; 35(2 Pt 2):215. PubMed ID: 3550639 [TBL] [Abstract][Full Text] [Related]
22. Effect of Y-24180, a long-acting antagonist to platelet-activating factor (PAF), on PAF-induced reactions: a relationship between the partial structure of the compound and its duration of the action. Kagoshima M; Tomomatsu N; Iwahisa Y; Yamaguchi S; Kawakami Y; Terasawa M Pharmacology; 1997 May; 54(5):261-70. PubMed ID: 9380772 [TBL] [Abstract][Full Text] [Related]
23. PAF and thrombin actions in platelets are selectively affected by a new 1,4-dihydropyridine derivative. Catalán RE; Martínez AM; Aragonés MD; Garde E; Lombardía M; Ortega P J Biochem; 1993 Apr; 113(4):450-5. PubMed ID: 8390447 [TBL] [Abstract][Full Text] [Related]
24. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials. Macconi D; Benigni A; Morigi M; Ubiali A; Orisio S; Livio M; Perico N; Bertani T; Remuzzi G; Patrono C J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212 [TBL] [Abstract][Full Text] [Related]
25. Inhibition by glaucocalyxin A of aggregation of rabbit platelets induced by ADP, arachidonic acid and platelet-activating factor, and inhibition of [3H]-PAF binding. Bin Z; Kun L Thromb Haemost; 1992 Apr; 67(4):458-60. PubMed ID: 1631795 [TBL] [Abstract][Full Text] [Related]
26. Antithrombotic activity of clove oil. Saeed SA; Gilani AH J Pak Med Assoc; 1994 May; 44(5):112-5. PubMed ID: 8078176 [TBL] [Abstract][Full Text] [Related]
27. Biochemical and pharmacological activities of SR 27417, a highly potent, long-acting platelet-activating factor receptor antagonist. Herbert JM; Bernat A; Valette G; Gigo V; Lale A; LaPlace MC; Lespy L; Savi P; Maffrand JP; Le Fur G J Pharmacol Exp Ther; 1991 Oct; 259(1):44-51. PubMed ID: 1656029 [TBL] [Abstract][Full Text] [Related]
28. Pharmacological profile of epiyangambin: a furofuran lignan with PAF antagonist activity. Castro-Faria-Neto HC; Martins MA; Silva PM; Bozza PT; Cruz HN; de Queiroz-Paulo M; Kaplan MA; Cordeiro RS J Lipid Mediat; 1993 May; 7(1):1-9. PubMed ID: 8358020 [TBL] [Abstract][Full Text] [Related]
29. Inhibitory effect of curcumin, a food spice from turmeric, on platelet-activating factor- and arachidonic acid-mediated platelet aggregation through inhibition of thromboxane formation and Ca2+ signaling. Shah BH; Nawaz Z; Pertani SA; Roomi A; Mahmood H; Saeed SA; Gilani AH Biochem Pharmacol; 1999 Oct; 58(7):1167-72. PubMed ID: 10484074 [TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of a selective thromboxane A2 receptor antagonist, EP 092, on platelet aggregation in whole blood ex vivo and in vivo. Booth RF; Honey AC; Lad N; Tuffin DP; Wade PJ Br J Pharmacol; 1989 Feb; 96(2):395-405. PubMed ID: 2522336 [TBL] [Abstract][Full Text] [Related]
32. Dual inhibition of platelet-activating factor and arachidonic acid metabolism by ajmaline and effect on carrageenan-induced rat paw oedema. Saeed SA; Simjee RU; Mahmood F; Rahman NN J Pharm Pharmacol; 1993 Aug; 45(8):715-9. PubMed ID: 7901369 [TBL] [Abstract][Full Text] [Related]
33. PAF antagonism in vitro and in vivo by aglafoline from Aglaia elliptifolia Merr. Ko FN; Wu TS; Liou MJ; Huang TF; Teng CM Eur J Pharmacol; 1992 Jul; 218(1):129-35. PubMed ID: 1327822 [TBL] [Abstract][Full Text] [Related]
34. Pharmacological activities of a novel thienodiazepine derivative as a platelet-activating factor antagonist. Tsunoda H; Sakuma Y; Harada K; Muramoto K; Katayama S; Horie T; Shimomura N; Clark R; Miyazawa S; Okano K Arzneimittelforschung; 1990 Nov; 40(11):1201-5. PubMed ID: 2085331 [TBL] [Abstract][Full Text] [Related]
35. CV-3988 - a specific antagonist of platelet activating factor (PAF). Terashita Z; Tsushima S; Yoshioka Y; Nomura H; Inada Y; Nishikawa K Life Sci; 1983 Apr; 32(17):1975-82. PubMed ID: 6403793 [TBL] [Abstract][Full Text] [Related]
36. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb. Hsiao G; Ko FN; Jong TT; Teng CM Biol Pharm Bull; 1998 Jul; 21(7):688-92. PubMed ID: 9703250 [TBL] [Abstract][Full Text] [Related]
37. Antiplatelet activity of some prenylflavonoids. Lin CN; Shieh WL; Ko FN; Teng CM Biochem Pharmacol; 1993 Jan; 45(2):509-12. PubMed ID: 8435100 [TBL] [Abstract][Full Text] [Related]
38. A potent inhibitor of platelet activating factor from the saliva of the leech Hirudo medicinalis. Orevi M; Rigbi M; Hy-Am E; Matzner Y; Eldor A Prostaglandins; 1992 May; 43(5):483-95. PubMed ID: 1584997 [TBL] [Abstract][Full Text] [Related]
39. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets. Nunez D; Kumar R; Hanahan DJ Arch Biochem Biophys; 1989 Aug; 272(2):466-75. PubMed ID: 2502069 [TBL] [Abstract][Full Text] [Related]
40. Roles of platelet-activating factor, thromboxane A2, ADP and thrombin in thrombogenesis in the guinea pig. Hirata Y; Takiguchi Y; Wada K; Matsuno H; Umemura K; Uematsu T; Nakashima M Eur J Pharmacol; 1993 Feb; 231(3):421-5. PubMed ID: 8449234 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]